Contact |
General |
Specializations in Countries |
Contribution to the Global Plan |
Declaration |
View this partner's profile
Organization Contact Information |
Name: |
Division of Tuberculosis Elimination, Centers for Disease Control and Prevention (CDC), U.S. Department of Health and Human Services (USDHHS) |
Street 1: |
1600 Clifton Road (E-10) |
Street 2: |
|
City: |
Atlanta |
Province: |
Georgia |
Post Code: |
30333 |
Country: |
United States of America |
Phone: |
4046398120 |
Organization Email: |
pgl5@cdc.gov |
Web Site: |
http://www.cdc.gov/nchstp/tb |
Other Online Presence: |
|
Focal Point Contact Information |
Salutation: |
Dr |
First Name: |
Philip |
Last Name: |
LoBue |
Title: |
Director, CDC/ Division of Tuberculosis Elimination |
Email: |
pgl5@cdc.gov |
Phone: |
|
|
Alternate Focal Point Contact Information |
Salutation: |
Dr |
First Name: |
Philip |
Last Name: |
LoBue |
Title: |
Director, CDC/ Division of Tuberculosis Elimination |
Email: |
pgl5@cdc.gov |
Phone: |
|
|
General Information |
Board Constituency: |
Technical agencies |
Is your organization legally registered in your country: |
Yes |
If yes, please enter your registration number: |
|
Organization Type - Primary: |
Governmental Organization |
Organization Type - Secondary: |
None |
Organization Description: |
The Division of Tuberculosis Elimination at CDC/USDHHS is the equivalent of the National Tuberculosis Control Program for the United States. We coordinate national research and program activities with other federal organizations in the United States (e.g., Food and Drug Administration, National Institutes of Health) through the Federal Tuberculosis Task Force, and with local and state tuberculosis programs through the National Tuberculosis Controllers Association. Additionally, in response to epidemiologic trends in the United States and recommendations by the U.S. Institute of Medicine, our agency provides technical support to global tuberculosis control effors by focusing on expanding access to DOTS in high-burden countries, by sharing lessons gained through the unprecedented 1985-1992 resurgence of tuberculosis and multidrug resistant TB (DOTS-plus), and to improve control of TB/HIV as part of the President's Emergency Plan for AIDS Relief (PEPFAR).
CDC is one of the founding members of the STOP TB Partnership, and remains committed to the global prevention and control of tuberculosis. |
|
Do you know about the UNHLM declaration: |
|
Specializations / Areas of Work |
Delivery of health services and care Funding, including innovative and optimized approach to funding TB Care Research and Development Technical Assistance |
Other Organization Information |
Total number of staff in your organization: |
6 - 10 |
Number of full-time staff who are directly involved with TB: |
6 - 10 |
Number of part-time staff who are directly involved with TB: |
0 |
Number of volunteers who are directly involved with TB: |
0 |
|
How did you hear about the Stop TB Partnership: |
Involvement in TB control provision |
If you were informed or referred by another partner of the Stop TB Partnership please tell us who: |
|
Why do you wish join the Stop TB Partnership: |
Involvement in Stop TB Working Groups |
|
Are you a member of a Stop TB national partnership: |
No |
Are you in contact with your national TB programme: |
Yes |
Please tell us how your organization is contributing to your country's national TB control plan: |
CDC is the national TB programme in the US. |
|
Geographical Reach |
Which country is your headquarters located in: |
United States of America |
Which countries do you do operate in: (This includes countries you are conducting activities in) |
United States of America |
Contribution |
Please tell us how your organization will contribute to the Global Plan to Stop TB by briefly describing its involvement in any of the areas of work listed below: |
TB Care Delivery: Our agency provides technical support to global tuberculosis control effors by focusing on expanding access to DOTS in high-burden countries, by sharing lessons gained through the unprecedented 1985-1992 resurgence of tuberculosis and multidrug resistant TB (DOTS-plus), and to improve control of TB/HIV as part of the President's Emergency Plan for AIDS Relief (PEPFAR).
Drug-Resistant TB: Our agency provides technical support to global tuberculosis control effors by focusing on expanding access to DOTS in high-burden countries, by sharing lessons gained through the unprecedented 1985-1992 resurgence of tuberculosis and multidrug resistant TB (DOTS-plus), and to improve control of TB/HIV as part of the President's Emergency Plan for AIDS Relief (PEPFAR).
TB-HIV: Our agency provides technical support to global tuberculosis control effors by focusing on expanding access to DOTS in high-burden countries, by sharing lessons gained through the unprecedented 1985-1992 resurgence of tuberculosis and multidrug resistant TB (DOTS-plus), and to improve control of TB/HIV as part of the President's Emergency Plan for AIDS Relief (PEPFAR). |
Declaration |
Declaration of interests:
No conflicts of interest were delacred.
|
Application date: |
|
Last updated: |
August 18, 2014 |
|